Near Infrared Imaging Market Size, Share & Forecast Analysis to 2030

The global near infrared imaging market size w valued at around USD 2 billion in 2025 and projected to grow at a significant CAGR of around 10% during the forecast period from 2026 to 2030. The market is experiencing steady growth, driven by the increasing adoption of fluorescence-guided imaging in surgical procedures, advancements in imaging technologies, and the rising prevalence of cancer and cardiovascular diseases. The growing demand for minimally invasive surgeries and real-time intraoperative visualization is accelerating the adoption of NIR imaging systems across hospitals and research institutions.

Market Snapshot:

Key Insights:

• Devices represented the dominant product segment, driven by increasing demand for near-infrared fluorescence imaging systems in surgical and diagnostic applications.
• Cancer Surgeries emerged as the leading application segment owing to the growing use of fluorescence-guided imaging for tumor localization and intraoperative margin assessment.
• North America accounted for the largest share of the global Near Infrared Imaging Market, supported by advanced healthcare infrastructure and high adoption of fluorescence-guided surgery.
• Technological advancements in imaging systems, fluorescence probes, and AI-enabled image analysis are expanding the clinical applications of near-infrared imaging.

Key Factors Driving the Near Infrared Imaging Market Growth

The increasing adoption of fluorescence-guided surgery (FGS) is a major driver of the near infrared imaging market. NIR imaging enables surgeons to visualize blood vessels, lymph nodes, tumors, and tissue perfusion in real time, improving surgical precision while reducing complications. The growing prevalence of cancer, cardiovascular diseases, and gastrointestinal disorders has further accelerated the demand for advanced imaging technologies that support minimally invasive procedures and improve patient outcomes. In addition, continuous advancements in imaging hardware, fluorescence cameras, and contrast agents are expanding the clinical applications of near-infrared imaging across multiple surgical specialties.

Another significant growth driver is the increasing regulatory approval and commercialization of fluorescence imaging technologies. In April 2024, the U.S. Food and Drug Administration (FDA) approved LUMISIGHT (pegulicianine), an optical fluorescence imaging drug indicated for use in adults with breast cancer to assist surgeons in detecting residual cancerous tissue following lumpectomy when used with the Lumicell Direct Visualization System (DVS) or another FDA-approved fluorescence imaging device. This approval highlights the expanding clinical adoption of fluorescence-guided near-infrared imaging and is expected to accelerate demand for advanced NIR imaging systems in surgical oncology.

Key Growth Drivers:

• Growing adoption of fluorescence-guided and minimally invasive surgeries is increasing demand for near-infrared imaging systems that enhance surgical precision and patient outcomes.
• Rising prevalence of cancer and cardiovascular diseases is driving healthcare providers to adopt advanced imaging technologies for accurate diagnosis and treatment.
• Continuous advancements in near-infrared imaging systems and imaging sensors are expanding clinical applications, improving visualization quality, and supporting wider adoption across healthcare facilities.

Near Infrared Imaging Market Restraining Factors

The high cost of near-infrared imaging systems and associated fluorescence imaging equipment remains a significant challenge for market growth. The installation of advanced imaging platforms requires substantial capital investment, while ongoing expenses for maintenance, software upgrades, and specialized consumables further increase the overall cost of ownership. These financial barriers limit the adoption of NIR imaging technologies, particularly among small and medium-sized hospitals, ambulatory surgical centers, and healthcare facilities in developing economies.

Another major restraint is the limited availability of skilled professionals and standardized clinical protocols for near-infrared imaging procedures. Effective utilization of NIR imaging systems requires specialized training to accurately interpret fluorescence signals and integrate the technology into surgical workflows. In addition, varying reimbursement policies and regulatory requirements across different countries can delay technology adoption and reduce investment in advanced imaging solutions, thereby restraining overall market expansion.

Growth Opportunities in the Global Near Infrared Imaging Market

The expanding adoption of precision medicine and fluorescence-guided surgery presents significant growth opportunities for the near infrared imaging market. Increasing demand for real-time visualization during oncological, cardiovascular, and reconstructive procedures is encouraging healthcare providers to invest in advanced NIR imaging systems. Moreover, the integration of artificial intelligence, high-sensitivity detectors, and hybrid imaging platforms is expected to improve diagnostic accuracy and broaden the clinical applications of near-infrared imaging across hospitals and research centers.

Growing investments in life science research and the development of advanced fluorescence probes are further creating lucrative opportunities for market participants. In March 2024, artience Co., Ltd. launched the Sciforiem FI Series, a high-sensitivity near-infrared fluorescence probe in Japan designed to enhance cell and exosome dynamics observation for therapeutic and diagnostic applications. This launch highlights the increasing innovation in NIR imaging technologies and their expanding use in biomedical research and precision diagnostics.

Key Growth Opportunities:

• Expanding adoption of fluorescence-guided surgery is creating opportunities for advanced near-infrared imaging systems across oncology, cardiovascular, and reconstructive procedures.
• Increasing investments in biomedical research and precision medicine are driving demand for high-performance near-infrared imaging platforms and fluorescence probes.
• Integration of artificial intelligence and advanced imaging software is improving image analysis, enabling broader clinical applications and supporting future market expansion.

Industry Trends Shaping the Global Near Infrared Imaging Market

The near infrared imaging market is witnessing increasing adoption of fluorescence-guided and image-guided surgical procedures as healthcare providers seek to improve surgical precision and patient outcomes. Technological advancements in high-resolution cameras, multispectral imaging, and AI-assisted image analysis are enhancing real-time visualization and expanding the use of near-infrared imaging across oncology, cardiovascular, and reconstructive surgeries.

Another significant trend is the introduction of next-generation near-infrared fluorescence imaging systems designed for minimally invasive procedures. In June 2026, Getinge launched FLUOBEAM LS, expanding its fluorescence imaging portfolio for small-incision surgery. The system provides real-time visualization of anatomical structures during procedures such as thyroid surgery and sentinel lymph node detection in breast cancer, reflecting the growing industry focus on compact, high-performance NIR imaging technologies for precision surgery.

Market Segments Insights:

By Product Type, the Devices Segment Dominated the Global Near Infrared Imaging Market

On the basis of product type, the devices segment dominates the near infrared imaging market due to the increasing adoption of fluorescence-guided surgery and minimally invasive procedures across hospitals and specialty surgical centers. Growing demand for real-time visualization of blood vessels, lymph nodes, tissue perfusion, and tumors has accelerated the deployment of advanced near-infrared imaging systems. Continuous improvements in imaging resolution, software integration, and multispecialty compatibility have further strengthened the segment’s market leadership.

Within the Devices segment, Near-infrared Fluorescence Imaging Systems account for the largest market share because of their widespread use in oncology, cardiovascular, gastrointestinal, urological, and reconstructive surgeries. In March 2026, Olympus launched the VISERA ELITE™ III surgical imaging platform in the U.S., featuring 4K fluorescence-guided surgery (IR/ICG) imaging, narrow-band imaging, and multispecialty support in a single system. The launch reflects the industry’s continued investment in advanced near-infrared imaging devices, reinforcing the dominance of the Devices segment.

By Application, the Cancer Surgeries Sub-category Holds the Largest Share of Global Near Infrared Imaging Market

On the basis of application, the cancer surgeries segment dominates the near infrared imaging market owing to the increasing adoption of fluorescence-guided imaging for tumor localization, sentinel lymph node mapping, and intraoperative margin assessment. The rising global cancer burden and the growing preference for minimally invasive surgical procedures have accelerated the use of near-infrared imaging systems in surgical oncology. These systems provide real-time visualization of tumors and surrounding tissues, enabling surgeons to improve surgical precision, preserve healthy tissue, and reduce the likelihood of repeat surgeries.

The segment’s leadership is further supported by the expanding clinical use of approved near-infrared fluorescence imaging agents in oncology. According to the U.S. FDA-approved prescribing information for IC-GREEN (indocyanine green) updated in 2024, the imaging agent is indicated for fluorescence imaging of lymph nodes and lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer, demonstrating the expanding role of near-infrared fluorescence imaging in oncologic surgery and supporting continued demand for NIR imaging systems.

Global Near Infrared Imaging Market Segmentation:

By Type:

• Devices
  • Near-infrared Fluorescence Imaging Systems
  • Near-infrared Fluorescence & Bioluminescence Imaging Systems
• Reagents
  • Indocyanine Green (ICG)
  • Other Reagents

By Application:

• Preclinical Imaging
• Cancer Surgeries
• Cardiovascular Surgeries
• Gastrointestinal Surgeries
• Plastic & Reconstructive Surgeries
• Others

By End-User:

• Hospitals
• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Academic Institutions

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis: North America Leading the Global Near Infrared Imaging Market

Geographically, the North America dominates the global near infrared imaging market due to its advanced healthcare infrastructure, widespread adoption of fluorescence-guided surgery, and strong presence of leading medical device manufacturers. The region also benefits from significant investments in medical imaging research, favorable reimbursement policies, and the rapid integration of innovative imaging technologies across hospitals and academic medical centers. The increasing prevalence of cancer and cardiovascular diseases continues to drive demand for near-infrared imaging systems in clinical practice.

The region’s leadership is further reinforced by continuous regulatory approvals that accelerate the commercialization of advanced imaging technologies. In April 2024, the U.S. Food and Drug Administration (FDA) granted Premarket Approval (PMA) for the Lumicell Direct Visualization System (DVS), a fluorescence imaging device designed to detect residual breast cancer tissue during lumpectomy when used with LUMISIGHT (pegulicianine). This approval highlights North America’s strong regulatory support for near-infrared fluorescence imaging technologies and reinforces the region’s leading position in the market.

Competitive Analysis:

The near infrared imaging market is moderately consolidated, with leading companies focusing on technological innovation, regulatory approvals, product portfolio expansion, and strategic collaborations to strengthen their market positions. Key players are investing in the development of advanced fluorescence-guided imaging systems, high-sensitivity detectors, and innovative imaging reagents to improve surgical precision and expand applications across oncology, cardiovascular, gastrointestinal, and reconstructive procedures. Companies are also integrating artificial intelligence and high-definition imaging capabilities to enhance clinical performance and workflow efficiency.

Major market participants, including Carl Zeiss AG, Olympus Corporation, Leica Microsystems, Hamamatsu Photonics K.K., Medtronic plc, Stryker Corporation, KARL STORZ SE & Co. KG, Shimadzu Corporation, and PerkinElmer Inc., are strengthening their competitive positions through continuous product innovation, geographic expansion, and partnerships with healthcare providers and research institutions. In addition, increasing investments in fluorescence-guided surgery and precision medicine are encouraging manufacturers to develop next-generation near-infrared imaging solutions that address the growing demand for real-time intraoperative visualization and advanced diagnostic capabilities.

Key Companies:

• Carl Zeiss AG
• Olympus Corporation
• Leica Microsystems
• Hamamatsu Photonics K.K.
• Medtronic plc
• Stryker Corporation
• KARL STORZ SE & Co. KG
• Shimadzu Corporation
• Revvity, Inc. (formerly PerkinElmer)
• Quest Medical Imaging B.V.
• Mizuho Medical Co., Ltd.
• Fluoptics (Getinge)

Global Near Infrared Imaging Market Outlook

• Increasing adoption of fluorescence-guided and minimally invasive surgeries will continue to drive demand for advanced near-infrared imaging systems across multiple surgical specialties.
• Continuous technological advancements, including AI-enabled image analysis, high-resolution cameras, and multispectral imaging, are expected to enhance imaging accuracy and clinical efficiency.
• Expanding clinical applications in oncology, cardiovascular, gastrointestinal, plastic, and reconstructive surgeries will create new growth opportunities for market participants.
• Rising regulatory approvals and commercialization of innovative imaging systems and fluorescence agents will accelerate product adoption and strengthen market competitiveness.
• Growing investments in biomedical research, precision medicine, and next-generation imaging technologies are expected to support sustained market growth throughout the forecast period.

Frequently Asked Questions About the Near Infrared Imaging Market